| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CITIGROUP INC | 271,800 | 40,000 | 0.00% | ||
| 2 | NUVEEN ALL CAP ENE MLP OPPO | 15,000 | 158,000 | 0.01% | ||
| 3 | GABELLI MULTIMEDIA TR INC | 20,600 | 166,000 | 0.01% | ||
| 4 | ABERDEEN AUSTRALIA EQUITY FD | 27,500 | 167,000 | 0.01% | ||
| 5 | ABERDEEN GTR CHINA FD INC | 16,700 | 175,000 | 0.01% | ||
| 6 | NEUBERGER BERMAN INTER MUNI | 11,900 | 177,000 | 0.01% | ||
| 7 | ABERDEEN EMERGING MKTS SMALL | 13,646 | 178,000 | 0.01% | ||
| 8 | GABELLI CONV&INCOM SECS FD I | 36,343 | 178,000 | 0.01% | ||
| 9 | GUGGENHEIM ENHANCED EQUITY I | 23,728 | 192,000 | 0.01% | ||
| 10 | COHEN & STEERS GLOBAL INCORPORATED BLDR | 22,043 | 202,000 | 0.01% | ||
| 11 | B & G FOODS INC NEW COM | 5,100 | 205,000 | 0.01% | ||
| 12 | GABELLI EQUITY TR INC | 36,120 | 216,000 | 0.01% | ||
| 13 | ROLLINS INC | 6,500 | 241,000 | 0.02% | ||
| 14 | CARTERS INC | 2,700 | 242,000 | 0.02% | ||
| 15 | CREDIT SUISSE ASSET MGMT INC | 93,095 | 307,000 | 0.02% | ||
| 16 | COHEN & STEERS QUALITY RLTY | 25,800 | 317,000 | 0.02% | ||
| 17 | UNITEDHEALTH GROUP INC | 2,000 | 328,000 | 0.02% | ||
| 18 | LATIN AMERN DISCOVERY FD INC | 32,100 | 338,000 | 0.02% | ||
| 19 | ZELTIQ AESTHETICS INC | 8,200 | 357,000 | 0.02% | ||
| 20 | ROYCE VALUE TR INC | 27,641 | 387,000 | 0.02% | ||
| 21 | MONRO MUFFLER BRAKE INC | 7,800 | 406,000 | 0.03% | ||
| 22 | DUFF PHELPS UTLITY AND INF | 25,000 | 407,000 | 0.03% | ||
| 23 | WELLS FARGO GLOBAL DIVID OPP | 72,800 | 424,000 | 0.03% | ||
| 24 | PRINCIPAL REAL ESTATE INCOME | 24,812 | 435,000 | 0.03% | ||
| 25 | AVENUE INCOME | 32,839 | 458,000 | 0.03% | ||
| 26 | CAMBREX CORP | 9,100 | 501,000 | 0.03% | ||
| 27 | NUVEEN FLOATING RATE INCOME | 46,700 | 538,000 | 0.03% | ||
| 28 | First Trust/Aberdeen Global | 49,806 | 579,000 | 0.04% | ||
| 29 | INTELLIA THERAPEUTICS INC | 42,600 | 600,000 | 0.04% | ||
| 30 | BLACKROCK RES COMMODITIES | 70,500 | 606,000 | 0.04% | ||
| 31 | FLAHERTY CRUMRINE PFD SECS | 31,100 | 639,000 | 0.04% | ||
| 32 | UNITED THERAPEUTICS CORP DEL | 4,500 | 645,000 | 0.04% | ||
| 33 | BLUEBIRD BIO INC COM | 7,100 | 645,000 | 0.04% | ||
| 34 | KERYX BIOPHARMACEUTICALS INCORPORATED | 106,700 | 657,000 | 0.04% | ||
| 35 | MORGAN STANLEY CHINA A SH FD | 35,100 | 675,000 | 0.04% | ||
| 36 | PIONEER HIGH INCOME TR | 69,300 | 684,000 | 0.04% | ||
| 37 | DOUBLELINE OPPORTUNISTIC CR | 29,420 | 702,000 | 0.04% | ||
| 38 | INCYTE CORP | 5,900 | 789,000 | 0.05% | ||
| 39 | DREYFUS HIGH YIELD STRATEGIE | 239,107 | 811,000 | 0.05% | ||
| 40 | TEKLA LIFE SCIENCES INVS | 48,545 | 825,000 | 0.05% | ||
| 41 | VOYA GLBL EQTY DIV & PREM OP | 115,900 | 851,000 | 0.05% | ||
| 42 | TARENA INTL INC | 51,700 | 899,000 | 0.06% | ||
| 43 | FIRST TR DYNAMIC EUROPE EQT | 52,600 | 908,000 | 0.06% | ||
| 44 | PACHOLDER HIGH YIELD FD INC | 124,140 | 958,000 | 0.06% | ||
| 45 | CLOVIS ONCOLOGY INC | 15,900 | 1,012,000 | 0.06% | ||
| 46 | PACIRA PHARMACEUTICALS INC | 22,800 | 1,040,000 | 0.07% | ||
| 47 | AETNA INC NEW | 8,200 | 1,046,000 | 0.07% | ||
| 48 | NETEASE INC | 3,700 | 1,051,000 | 0.07% | ||
| 49 | DOUBLELINE INCOME SOLUTIONS | 53,900 | 1,082,000 | 0.07% | ||
| 50 | GOLDMAN SACHS BDC INC | 53,000 | 1,306,000 | 0.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-005397, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
